- Home
- / Ascentage Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ascentage Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$45.5
2024-10-29
Market Capitalization
$14 B
2024-10-29
Revenue
¥574.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.8M | 14.5M | 12.5M | 27.9M | 209.7M | 222.0M | 980.6M | 574.1M |
| Cost of goods sold | 2.1M | 2.0M | 3.3M | 22.0M | 30.5M | 29.1M | 48.9M | |
| Gross profit | 27.8M | 43.0M | 31.1M | 88.1M | 223.5M | 213.9M | 964.4M | 546.6M |
| Gross profit margin, % | 408.8% | 296.2% | 249.7% | 315.5% | 106.6% | 96.4% | 98.3% | 95.2% |
| Operating expense total | 346.6M | 1.5B | 697.5M | 979.8M | 1.0B | 994.7M | 1.2B | 1.7B |
| Depreciation and amortization | 18.5M | 26.4M | 27.4M | 28.3M | 62.9M | 93.2M | 93.2M | 86.5M |
| EBITDA | (318.8M) | (1.5B) | (666.4M) | (891.8M) | (790.3M) | (779.8M) | (281.3M) | (1.1B) |
| EBITDA margin, % | -4683.6% | -10129.9% | -5352.9% | -3195.2% | -376.9% | -351.3% | -28.7% | -198.0% |
| EBIT | (331.4M) | (1.5B) | (693.9M) | (920.1M) | (851.1M) | (873.0M) | (374.5M) | (1.2B) |
| EBIT margin, % | -4868.5% | -10312.0% | -5573.2% | -3296.7% | -405.9% | -393.3% | -38.2% | -213.1% |
| Interest income | 7.1M | 12.9M | 5.2M | 7.1M | 9.7M | 32.4M | 37.8M | 82.1M |
| Interest expense | 36.9M | 4.3M | 6.3M | 16.7M | 52.8M | 96.1M | 64.5M | 54.1M |
| Pre tax profit | (346.9M) | (1.5B) | (675.4M) | (832.2M) | (887.2M) | (932.9M) | (395.3M) | (1.2B) |
| Income tax expense | (1.6M) | (1.6M) | 2.2M | (49.8M) | (4.2M) | (7.1M) | 10.4M | 6.9M |
| Net Income | (345.3M) | (1.5B) | (677.6M) | (782.4M) | (882.9M) | (925.7M) | (405.7M) | (1.2B) |